News & Events
-
April 20, 2012
C-Path Initiative’s Work on Personalized Medicine Starts to Get Results
The Critical path Institute (C-Path), the US Food and Drug Administration (FDA)-supported public-private initiative working to advance personalized medicine, is advancing quickly and is bearing results, reports The Arizona Star. -
April 17, 2012
C-Path Looks to Speed Gene Based Therapies
Your doctor may soon – perhaps in a year – be able to order up a test to map out your entire genome, or genetic blueprint, and get it in about eight hours for about $100. That’s stunning news, considering the same test took up to a year and $100 million a decade ago, and... - April 17, 2012
-
April 14, 2012
Critical Path Institute Announces New Head of Operations
Critical Path Institute (C-Path) has announced that Steven T. Broadbent has been chosen as the next chief operating officer of C-Path. Mr. Broadbent takes over for Rick Myers, who recently stepped down from C-Path in order to focus on his role as Chairman of the Arizona Board of Regents. Mr. Myers will continue to serve... -
April 14, 2012
Future of medicine – the critical path forward
I saw a presentation yesterday by Carolyn Compton, the new head of C-PATH, the critical path institute located in Tucson, AZ. This group has the goal of accelerating the development of new medicines by working at the interface between pharmaceutical companies, academic researchers and clinicians, the FDA, and the public.